CCDTXCidara Therapeutics Inc

Cidara Therapeutics Inc

CDTX

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive CDTX chart
  • Mkt cap

    $6.96B

  • EV/Sales

    N/A

  • P/E ratio

    N/A

  • Revenue (qtr ended 2025-09-30)

    N/A

  • EPS (9mo ended 2025-09-30)

    $-7.00

  • Gross Margin (qtr ended 2025-09-30)

    N/A

  • Profit Margin (qtr ended 2025-09-30)

    N/A

  • Beta

    1.53

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

CDTX — Cidara Therapeutics Inc · $6.96B cap

CDTX Key Statistics

  • Market Cap: $6.96B

Cidara Therapeutics Inc latest statements

Each line names its own latest cached period. Full CDTX income, balance, and cash tables.

  • Net Income (Q3 2025)-$83.2M
  • Total Assets (Q3 2025)$518.6M
  • Free Cash Flow (FY2023)-$8.3M

CDTX FAQ

What industry is CDTX in?

Cidara Therapeutics Inc (CDTX) is a biotechnology company in the Healthcare sector.

What is CDTX's latest net income?

Latest cached Cidara Therapeutics Inc (CDTX) net income for Sep 30, 2025 was -$83.2M. Statements: https://lician.com/financials/cdtx

What is CDTX's market cap?

Cidara Therapeutics Inc (CDTX) market capitalization is $6.96B on the latest cached snapshot.

Live CDTX terminal loads when you scroll near this section.